Entera Bio Ltd.
ENTX
Price:
$1.795
Market Cap:
$65.20M
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Ente...[Read more]
Industry
Biotechnology
IPO Date
2018-06-28
Stock Exchange
NASDAQ
Ticker
ENTX
PE Ratio
[-6.90]
ROE
[-100.37%]
Current Ratio
[7.41]
Dividend Yield
[0%]
Enterprise Value
[56.40M]
Dividend History
The ROE as of November 2024 (TTM) for Entera Bio Ltd. (ENTX) is -100.37%
According to Entera Bio Ltd.’s latest financial reports and current stock price. The company's current ROE is -100.37%. This represents a change of 281.44% compared to the average of -26.31% of the last 4 quarters.
Entera Bio Ltd. (ENTX) Historical ROE (quarterly & annually)
How has ENTX ROE performed in the past?
The mean historical ROE of Entera Bio Ltd. over the last ten years is -59.65%. The current -100.37% ROE has changed 68.28% with respect to the historical average. Over the past ten years (40 quarters), ENTX's ROE was at its highest in in the March 2023 quarter at 22.07%. The ROE was at its lowest in in the September 2019 quarter at -74.15%.
Average
-59.65%
Median
-85.59%
Minimum
-149.78%
Maximum
35.48%
Entera Bio Ltd. (ENTX) ROE by Quarter and Year
Discovering the peaks and valleys of Entera Bio Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 647.08%
Maximum Annual ROE = 35.48%
Minimum Annual Increase = -387.08%
Minimum Annual ROE = -149.78%
| Year | ROE | Change |
|---|---|---|
| 2023 | -85.59% | -23.04% |
| 2022 | -111.20% | 105.90% |
| 2021 | -54.01% | -63.94% |
| 2020 | -149.78% | 64.10% |
| 2019 | -91.27% | -10.39% |
| 2018 | -101.86% | -387.08% |
| 2017 | 35.48% | 647.08% |
| 2016 | 4.75% | -71.51% |
Entera Bio Ltd. (ENTX) Average ROE
How has ENTX ROE performed in the past?
The current ROE of Entera Bio Ltd. (ENTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-83.60%
5-year avg
-98.37%
10-year avg
-59.65%
Entera Bio Ltd. (ENTX) ROE vs. Peers
How is ENTX’s ROE compared to its peers?
Entera Bio Ltd.’s ROE is less than NLS Pharmaceutics AG (22.54%), less than Vaccinex, Inc. (1.11%), greater than Alterity Therapeutics Limited (-144.97%), greater than Enochian Biosciences, Inc. (-47.54%), greater than Immutep Limited (-42.11%),
| Company | ROE | Market cap |
|---|---|---|
| 22.54% | $10.61M | |
| 1.11% | $9.06M | |
| -144.97% | $10.11M | |
| -47.54% | $45.38M | |
| -42.11% | $267.64M |
Build a custom stock screener for Entera Bio Ltd. (ENTX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entera Bio Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Entera Bio Ltd. (ENTX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Entera Bio Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Entera Bio Ltd.'s ROE?
How is the ROE calculated for Entera Bio Ltd. (ENTX)?
What is the highest ROE for Entera Bio Ltd. (ENTX)?
What is the 3-year average ROE for Entera Bio Ltd. (ENTX)?
What is the 5-year average ROE for Entera Bio Ltd. (ENTX)?
How does the current ROE for Entera Bio Ltd. (ENTX) compare to its historical average?